Chung-Han Lee

14PUBLICATIONS
92CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 21, 2023
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.

Ritesh R Kotecha, Andrea Knezevic, Kanika Arora

|Sep 08, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.

Brendan J Guercio, Michal Sarfaty, Min Yuen Teo

|Nov 12, 2022
Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascade.

Kelly N Fitzgerald, Robert J Motzer, Chung-Han Lee

|Oct 03, 2022
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade.

Yasser Ged, Alejandro Sanchez, Sujata Patil

|Jul 28, 2022
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine.

Ramin Sedaghat Herati, David A Knorr, Laura A Vella

|Jul 07, 2022
Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell Carcinoma.

Ritesh R Kotecha, Erika Gedvilaite, Ryan Ptashkin

Pageof 3

Frequent Collaborators

10 joint publications

Robert Motzer

7 joint publications

Martin H Voss

4 joint publications

Andrea Knezevic

4 joint publications

Samuel A Funt